BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 18410913)

  • 1. Pharmacology of glucocorticoids: beyond receptors.
    van der Laan S; Meijer OC
    Eur J Pharmacol; 2008 May; 585(2-3):483-91. PubMed ID: 18410913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone.
    Roohk DJ; Varady KA; Turner SM; Emson CL; Gelling RW; Shankaran M; Lindwall G; Shipp LE; Scanlan TS; Wang JC; Hellerstein MK
    J Pharmacol Exp Ther; 2010 Apr; 333(1):281-9. PubMed ID: 20065017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of glucocorticoid action.
    Gower WR
    J Fla Med Assoc; 1993 Oct; 80(10):697-700. PubMed ID: 8270904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
    Haller J; Mikics E; Makara GB
    Front Neuroendocrinol; 2008 May; 29(2):273-91. PubMed ID: 18054070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid action and the development of selective glucocorticoid receptor ligands.
    Cole TJ
    Biotechnol Annu Rev; 2006; 12():269-300. PubMed ID: 17045197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
    McMaster A; Ray DW
    Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptor coregulator diversity: what can it mean for the stressed brain?
    Meijer OC; van der Laan S; Lachize S; Steenbergen PJ; de Kloet ER
    Neuroscience; 2006; 138(3):891-9. PubMed ID: 16310313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M; Stahn C; Hommes DW; Buttgereit F
    Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
    Stahn C; Löwenberg M; Hommes DW; Buttgereit F
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-genomic glucocorticoid effects to provide the basis for new drug developments.
    Song IH; Buttgereit F
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):142-6. PubMed ID: 16388891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic.
    Chrousos GP; Kino T
    Sci STKE; 2005 Oct; 2005(304):pe48. PubMed ID: 16204701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociated glucocorticoid receptor ligands.
    Schäcke H; Rehwinkel H
    Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
    Chinenov Y; Rogatsky I
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease: regulation of glucocorticoid and receptor levels--impact on the metabolic syndrome.
    Witchel SF; DeFranco DB
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):621-31. PubMed ID: 17082809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid involvement in memory consolidation].
    Sandi C
    Rev Neurol; 2003 Nov 1-15; 37(9):843-8. PubMed ID: 14606053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of apoptosis in lymphocytes by glucocorticoids: between physiology and pharmacology].
    Pallardy M; Biola A
    C R Seances Soc Biol Fil; 1998; 192(6):1051-63. PubMed ID: 10101602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
    Schäcke H; Rehwinkel H; Asadullah K; Cato AC
    Exp Dermatol; 2006 Aug; 15(8):565-73. PubMed ID: 16842594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.